ArticleSexual medicine2026
Age at first sexual intercourse and frailty: Mendelian randomization and population-based evidence from NHANES and UK Biobank.
Article in Sexual medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Age at first sexual intercourse (AFS) is an indicator of sexual initiation and may reflect broader life-course trajectories, but its relationship with frailty remains unclear. To examine genetic evidence for a potential association between AFS and frailty and to characterize nonlinear, threshold, and sex-specific patterns in population-based observational analyses. Methods: We performed Mendelian randomization (MR) analyses using summary statistics for AFS and frailty. We further analyzed data from the National Health and Nutrition Examination Survey (NHANES; Results: MR analyses showed that genetically predicted earlier AFS was associated with higher frailty risk (β = -0.30; 95% CI, -0.36 to -0.25), with similar estimates in males (β = -0.23; 95% CI, -0.30 to -0.16) and females (β = -0.22; 95% CI, -0.30 to -0.13). In observational analyses, restricted cubic spline models showed significant L-shaped associations between AFS and frailty in both NHANES and UKB. AFS <15 years was not significantly associated with frailty in the overall analyses. Compared with the third quintile of AFS, participants in the first and second quintiles had 61% (OR = 1.61, 95% CI: 1.40-1.85) and 19% (OR = 1.19, 95% CI, 1.05-1.41) higher odds of frailty, respectively, whereas fifth quintiles had 23% (OR = 0.77, 95% CI, 0.64-0.91) lower odds of frailty in NHANES; participants in the first quintile had 34% (OR = 1.34, 95% CI, 1.18-1.52) higher odds of frailty in UKB. Threshold analyses identified integer cut points of 21 years in NHANES and 23 years in UKB. Below these thresholds, later AFS was associated with lower odds of frailty; above them, associations were not statistically significant. Conclusion: MR analyses provided genetic evidence consistent with a potential association between earlier AFS and higher frailty risk, while population-based analyses showed an L-shaped association among middle-aged and older adults. These findings should be interpreted cautiously and not as definitive evidence of causality. Earlier AFS may be relevant to frailty risk later in life, supporting safe, informed, and rights-based sexual development rather than defining an optimal age for sexual debut.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.